Cardiometabolic disease, a term encompassing a cluster of conditions that increase the risk of cardiovascular disease and metabolic disorders, represents a significant health challenge in today's society. This multifaceted group includes conditions such as obesity, type 2 diabetes, and hypertension, which collectively contribute to an elevated risk of heart disease and stroke. The intricate interplay between genetics, lifestyle factors, and environmental influences underscores the complexity of cardiometabolic diseases. Sedentary lifestyles, poor dietary choices, and genetic predispositions can contribute to the development and progression of these interconnected conditions. Early detection and comprehensive management strategies are crucial in mitigating the impact of cardiometabolic disease, emphasizing the importance of lifestyle modifications, medication adherence, and regular health screenings. Public health initiatives aimed at promoting awareness, education, and preventive measures play a pivotal role in addressing the rising prevalence of cardiometabolic disease and fostering a healthier population.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India